Notice for belumosudil (Kadmon Oceania Pty Ltd)
Active ingredients
belumosudil
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
Treatment of Graft versus Host Disease
Therapeutic area
Oncology